Pro: The practice of cardiac anesthesia has changed after the withdrawal of aprotinin

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 24, Issue 5, 2010, Pages 875-878

  Spiess, Bruce D ^a   Milas, Bonnie L ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

aprotinin; epsilon aminocaproic acid; lysine analogs; mortality; outcomes; renal failure; tranexamic acid; transfusion

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD CLOTTING FACTOR 7A; FRESH FROZEN PLASMA; TRANEXAMIC ACID;

ANESTHESIOLOGICAL TECHNIQUES; ARTIFICIAL VENTILATION; BLEEDING; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; COST BENEFIT ANALYSIS; CRYOPRECIPITATE; DISEASE SEVERITY; DRUG COST; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; KIDNEY FAILURE; MEDICAL PRACTICE; MORTALITY; PRIORITY JOURNAL; REVIEW; SEIZURE; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS;

EID: 77957690686     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.07.009     Document Type: Note

References (30)

1. M.K. Banbury M.E. Brizzio J. Rajeswaran Transfusion increases the risk of postoperative infection after cardiac surgery J Am Coll Surg 202 2006 131 138
2. M.C. Engoren R.H. Habib A. Zacharias Effect of blood transfusion on long-term survival after cardiac operation Ann Thorac Surg 74 2002 1180 1186
3. S. Basran R.J. Frumento A. Cohen The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery Anesth Analg 103 2006 15 20
4. C.G. Koch F. Khandwala L. Li Persistent effect of red cell transfusion on health-related quality of life after cardiac surgery Ann Thorac Surg 82 2006 13 20
5. T. Veenith L. Sharples C. Gerrard Survival and length of stay following blood transfusion in octogenarians following cardiac surgery Anaesthesia 65 2010 331 336
6. D.T. Mangano J.C. Tudor C. Dietzel Multicenter study of Perioperative Research Group, Ischemia Research Education Foundation The risk associated with aprotinin in cardiac surgery N Engl J Med 254 2006 353 365
7. K. Katkouti W.S. Beattie K.M. Dattilo A propensity score case-control comparison of aprotinin and tranexamic acid in high transfusion-risk cardiac surgery Transfusion 46 2006 327 338
8. D.T. Mangano Y. Miao A. Vuylsteke Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery JAMA 297 2009 471 479
9. D. Fergusson P. Hébert C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
10. A.P. Furnary Y. Wu L.F. Hiratzka Aprotinin does not increase the risk of renal failure in cardiac surgery patients Circulation 116 suppl 2007 1127 1133
11. D. Pagano N.J. Howell N. Freemantle Bleeding in cardiac surgery: The use of aprotinin does not affect survival J Thorac Cardiovasc Surg 135 2008 495 502
12. K. Martin G. Wiesner T. Breuer The risk of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients Anesth Analg 107 2008 1783 1790
13. S.A. Snyder-Ramos P. Mohnle Y.S. Weng Multicenter Study of Perioperative Ischemia (McSPI) Research Group The ongoing variability in blood transfusion practices in cardiac surgery Transfusion 48 2008 1284 1299
14. A. Kulier J. Levin R. Moser Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery Circulation 116 2007 471 479
15. E. Ott C.D. Mazer I.C. Tudor Coronary artery bypass graft surgery-care globalization: The impact of national care on fatal and nonfatal outcome J Thorac Cardiovasc Surg 133 2007 1242 1251
16. S. Aronson M.L. Fontes Y. Miao Risk index for perioperative renal dysfunction/failure: Critical dependence on pulse pressure hypertension Circulation 115 2007 733 742
17. R.M. Sniecinski E.P. Chen S.S. Makadia Changing from aprotinin to tranexamic acid results in increased use of blood products and recombinant factor VIIa for aortic surgery requiring hypothermic arrest J Cardiothorac Vasc Anesth 2010 PMID 20430647 [Epub ahead of print]
18. X. Wang Z. Zheng A. Hushan A comparison before and after aprotinin was suspended in cardiac surgery: Different results in the real world from a single cardiac center in China J Cardiovasc Thorac Surg 138 2009 897 903
19. Z. Strouch M.L. Drum M.A. Chaney Aptrotinin use during cardiac surgery: Recent alterations and effects on blood product utilization J Clin Anesth 21 2009 502 507
20. D.L. Ngaage J.M. Bland Lessons from aprotinin: Is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomized and large matched observational studies Eur J Cardiothorac Surg 37 2010 1375 1383
21. V. McMullan R.P. Alston The effect of the suspension of the license for aprotinin on the care of patients undergoing cardiac surgery: A survey of cardiac anesthesiologists' and surgeons' opinions in the United Kingdom J Cardiothorac Vasc Anesth 24 2010 418 421
22. Reidert M, Lata A, Hamon J, et al: Substitution of aminocaproic acid for aprotinin in complex cardiac operations. Effects on bleeding indices and patient outcomes. Society of Thoracic Surgeons Annual Meeting 2007 (abstract). Presented with permission at the Food and Drug Administration Aprotinin Public Hearing, Silver Spring, MD, September 6, 2007
23. A. Davis R. Mandal M. Johnson A touch of TRALI Transfusion 48 2008 54 55
24. C. Koch L. Li P. Figueroa Transfusion and pulmonary morbidity after cardiac surgery Ann Thorac Surg 88 2009 1410 1418
25. J.M. Murkin F. Falter J. Granton High-dose tranexamic acid is associated with non-ischemic clinical seizures in cardiac surgical patients Anesth Analg 110 2010 350 353
26. K. Mohseni A. Jafri M.R. Nobahar Polyclonis seizure resulting from accidental injection of tranexamic acid in spinal anesthetic Anesth Analg 108 2009 1984 1986
27. R. Furtmüller M.G. Schlag M. Berger Tranexamic acid, a widely used antifibrinolytic agent causes convulsions by a gamma-aminobutyric acid (A) receptor antagonistic effect J Pharmacol Exp Ther 301 2002 168 173
28. T.M. Sundt The demise of aprotinin: Our share of the blame J Thorac Cardiovasc Surg 135 2008 729 731
29. A. DeAnda Aprotinin and cardiac surgery J Thorac Cardiovasc Surg 135 2008 492 494
30. K. Karkouti D.N. Wijeysundera T.M. Yau The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery Anesth Analg 110 2010 21 29